GreenThumb - stock earnings
GTII.CN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | 13.4 million USD | 252.4 million USD |
| 2022Q4 | -51.2 million USD | 259.3 million USD |
| 2022Q3 | 9.8 million CAD | 261.2 million CAD |
| 2022Q2 | 24.4 million CAD | 254.3 million CAD |
| 2022Q1 | 28.9 million CAD | 242.6 million CAD |
| 2021Q4 | 22.8 million CAD | 243.6 million CAD |
| 2021Q3 | 20.2 million USD | 233.7 million USD |
| 2021Q2 | 22.1 million USD | 221.9 million USD |
| 2021Q1 | 10.4 million USD | 194.4 million USD |
GTII.CN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | 12.0 million USD | 1.0 billion USD |
| 2021 | 75.4 million CAD | 893.6 million CAD |
| 2020 | 15.0 million CAD | 556.6 million CAD |
| 2019 | -59.1 million CAD | 216.4 million CAD |
| 2018 | -5.2 million CAD | 62.5 million CAD |
GTII.CN
Price: CA$16.65
52 week price:
Earnings Per Share: 0.20 CAD
P/E Ratio: -157.82
Exchange: CNQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 154849
Market Capitalization: 4.6 billion